Response Soars With Anti-PD-1 Drug for HER2-Positive Stomach Cancer Almost 50% relative increase in ORR with pembrolizumab plus trastuzumab and chemotherapy Jul 08, 2021
PD-1 Inhibitor Boosts Survival in Treated Esophageal Cancer Benefit with China-developed tislelizumab in all patients and EU-North American subgroup Jul 06, 2021
Woman Loses 6-Year Battle With Mouth Tumor Rare ameloblastoma rapidly recurs and metastasizes despite numerous radical excisions Jul 04, 2021
IVF Babies at No Increased Risk of Childhood Cancers No associations seen with intracytoplasmic sperm injection or frozen embryo transfer, study found Jul 02, 2021
House Members Argue for Puerto Rico Coal Plant Shutdown Plant is releasing toxic coal ash, sickening the nearby community, lawmakers and witnesses say Jul 01, 2021
'Clinically Meaningful' Survival Gain in Neuroendocrine Tumors Near 1-year improvement with radionuclide agent misses statistical significance Jul 01, 2021
Adjuvant Combo Boosts Survival in Resected Pancreatic Cancer Four-month gain in OS with the addition of nab-paclitaxel to gemcitabine Jun 30, 2021
Do 'Robots' Offer Any Clear Surgical Advantage? Review says no, and Vinay Prasad believes it's a sobering reflection on medical technology Jun 28, 2021 video
Adding PD-1 Inhibitor Shows Promise in Potentially Resectable HCC "Safe and successful conversion therapy" with hepatic arterial infusion chemo plus sintilimab Jun 28, 2021
Hold Off on Approving Anal Cancer Drug, Advisors Tell FDA ODAC recommends deferring approval of new PD-1 inhibitor until confirmatory trial results are in Jun 24, 2021
Start Thinking 'Cure'; One More Hug; Mortgages and Breast Cancer Survival News, features, and commentary about cancer-related issues Jun 16, 2021
The FDA Is Failing the American People The agency's recent decision to approve aducanumab offers more evidence of a broken system Jun 16, 2021
COVID Vaccine Protection; 'Until You Die From the Cancer'; What's Palliative Care? News, features, and commentary about cancer-related issues Jun 10, 2021
Bispecific Antibody Active in NRG1-Positive Pancreatic Cancer Zenocutuzumab turns in promising results in early-phase trial involving multiple solid tumors Jun 10, 2021
Promising Early Data for Bladder-Sparing Cancer Treatment Bladder-intact DFS at 1 year nears 90% for muscle-invasive bladder cancer Jun 09, 2021
Perioperative Chemo Enough in Esophageal Cancer? MAGIC/FLOT regimens yielded similar overall survival to multimodal CROSS regimen Jun 06, 2021
Small PFS Bump in Synovial Sarcoma With Novel Drug But questions raised over control arm and whether improvement represents a meaningful benefit Jun 05, 2021
PD-1 Inhibitor Shows Benefit in Nasopharyngeal Cancer Toripalimab plus first-line chemo improved survival in recurrent/metastatic disease Jun 03, 2021
Survival Boost With First-Line Immunotherapy for Esophageal Cancer Nivolumab plus ipilimumab or chemo offers new option for advanced, metastatic disease Jun 03, 2021
First-Line Chemo Plus Immunotherapy Falls Short in Bladder Cancer Adding pembrolizumab to cisplatin-based chemotherapy did not improve survival outcomes Jun 02, 2021
Radiation Speeds Up Biological Aging in Head and Neck Cancer Epigenetic age acceleration linked with greater inflammation and fatigue Jun 01, 2021
Bevacizumab Misses Mark in Untreated Metastatic Bladder Cancer No improvement in overall survival when added to cisplatin-containing chemotherapy Jun 01, 2021
Drug to Delay T1D Gets Tepid Endorsement by FDA Advisors Feelings mixed on safety and efficacy evidence for novel biologic May 28, 2021
Hospital at Home May Reduce Hospitalization, Costs for Cancer Patients Study demonstrated efficacy, cost-effectiveness of providing hospital-level services at home May 26, 2021
Lymph Node Findings on PET: Cancer or COVID Vaccine? Post-jab radiotracer uptake "could prompt unnecessary biopsies and treatments" May 26, 2021
Potassium Acid Blocker No Better Than PPI for Artificial Gastric Ulcers Small Japanese trial found similar outcomes with both drugs May 25, 2021
Op-Ed: A Door Opens to Transform Cancer Care Incoming CMS Administrator Chiquita Brooks-LaSure brings hope to the cancer community May 25, 2021
Test Can Predict Death Risk With Adrenal Tumors This can help guide need for surgical intervention, researcher says May 24, 2021
RET Fusion Inhibitor Active Beyond Lung, Thyroid Cancers Responses to selpercatinib in almost half of tumors outside approved indications May 21, 2021
CHS Sues Thousands of Patients; Hospital Parking Fees Under Fire; Trump-Era Emails This past week in healthcare investigations May 19, 2021
Impressive Results With Lenvatinib in Challenging Tumors Multitargeted TKI achieves strong ORR in advanced gastroenteropancreatic NETs May 10, 2021
No Clarity for Role of Laser Therapy in Vulvar Lichen Sclerosus Mixed results from two small randomized clinical trials May 10, 2021
Is Dynamic AFP-R Key to Transplant Selection in Liver Cancer? Dynamic alpha-fetoprotein response improved prediction of patient outcomes May 05, 2021
What's Behind the Mysterious Chest Pain in Bladder Cancer Patient? Cardiomyopathy risks interrupting cancer treatment, worsening prognosis May 03, 2021
'It's a Straw-Man Argument': What We Heard This Week Quotable quotes from 51³ΙΘΛΆ―Βώ's sources May 02, 2021
FDA Panel Splits on Anti-PD-1 Monotherapy in HCC All thumbs up for pembrolizumab, pending further data, but no such luck for nivolumab Apr 30, 2021
What to Do With a Rare, Aggressive Bladder Cancer Case authors lament scant information on treatments or outcomes Apr 26, 2021
PD-1 Inhibitor Approved for dMMR Endometrial Cancer Dostarlimab led to 42.3% response rate in recurrent/advanced disease Apr 22, 2021
Surveillance Spurned for Small Papillary Thyroid Tumors Nearly all head and neck surgeons would opt for lobectomy or total thyroidectomy Apr 22, 2021
Olympic Gold Medalist Nathan Adrian's Testicular Cancer The swimmer's diagnosis, treatment, and an "extra year" of pandemic prep for Toyko Apr 20, 2021
